Archives: Speakers

Based outside Ghent, Belgium, Stefaan Van der Meulen heads the Global Clinical Business Development team for NAMSA. Prior to this he was leading the Syntactx offices in Europe as a Managing Partner also overseeing business development for the company on a global scale.

Stefaan began his career in the pharmaceutical industry working on early- and late-phase clinical research studies of various sizes and indications. While working at Novartis, he was a global co-driver for their risk-based monitoring initiative, a best practice that is now being applied at Syntactx. At Cordis, a medical device developer and manufacturer, Stefaan concentrated on first-in-human and pivotal studies before transitioning to Core Laboratory and product specialist activities. He also has experience in product life-cycle development from both a clinical and marketing perspective.
Stefaan holds a Master of Biomedical Sciences from Ghent University in Belgium. He is fluent in Dutch, English, and French, and proficient in Italian and German.

Dr. Sofia de Achaval Wied is an epidemiologist with over 10 years of experience in clinical research. She began her career in Houston in psychosocial research and transitioned into research administration roles at leading academic research institutions in the Texas Medical Center. This year she expanded her clinical research and drug development experience by joining Tvardi Therapeutics, where she serves as the Executive Director of Research and Development.

Johnny has spent 10 years in Financial Technology companies, acting a consultant to potential clients on their technology requirements and appropriate solution. His expertise covers the full stack of systems required by leading Private Banks and Wealth Managers, encompassing core banking solutions, portfolio management solutions, Client Lifecycle Management (CLM) solutions and more. As Director of Pre-Sales Wealth Dynamix, Johnny uses his experience to help firms understand how CLM technology can be used to support the achievement of strategic business outcomes and, crucially, why such transformation makes sense from a business value perspective.

Yanna is a strategy and technology expert with extensive IT experience. Has successfully bridged the gap between business strategies and IT organisations. Has an established reputation in leading and delivering large-scale transformations. CIO (Head of IT) for Generali UK and for Generali Corporate and Commercial. Session Details: Welcoming digital change to the insurance business operating model and overcoming resistance to adapt